There are currently no established safety data specifically addressing GLP-1 agonist use in active Crohn's disease, requiring thorough informed consent, close monitoring, and coordination between specialists
When injecting GLP-1 medication into the arm, the correct anatomical location is the back of the upper arm , specifically the fatty tissue over the triceps muscle
Ranson H, Prapanthadara L and Hemingway J
Acknowledgements The present study was funded by the National Research Foundation of Korea through the Basic Science Research Program (NRF-2017M3A9B4061890, NRF-2017R1D1A1B03035059, NRF-2017M3A9D8062960, and NRF-2018R1A2B3008541)
These observations suggest that during pharmacological GLP-1R agonism, the net effect of -arrestin recruitment is to reduce prolonged insulin release